DIABEFIT AND METMORFIN IN CORRECTION OF LIPID METABOLISM IN PATIENTS WITH DIABETIC RETINOPATHY
Abstract
56 patients suffering from a diabetic retinopathy were included in the research; the complex analysis of dynamics of lipid metabolism indicators on the background of diabefit therapy in combination with metformin is carried out. The conclusion is drawn on expediency of application of basic therapy in combination with metformin and. diabefit for correction of violations of lipid metabolism in patients with diabetes.
About the Authors
E. B. Balzhinimayev
Buryat State University
Russian Federation
Russian Federation
G. F. Zhigayev
Buryat State University
Russian Federation
Russian Federation
M. P. Ryabov
Republican Clinical Hospital named after N.A. Semashko
Russian Federation
Russian Federation
References
1. Алмазова И.И., Аметов А.С., Автандилов А.Г. Эффективность медостатина (ловастатина) в коррекции липидного обмена у больных сахарным диабетом 2 типа и ишемической болезнью сердца // Фарматека. - 2006. - № 119 (134). - С. 62 - 65.
2. Астахов Ю.С. Лисочкина А.Б., Шадричев Ф.Е. Современные направления медикаментозного лечения непролиферативной диабетической ретинопатии // Клин. офтальм. - 2003. - Т. 4, № 3. - С. 96-101.
3. Шадричев Ф.Е. Практические аспекты офтальмологического ведения пациентов с пролиферативной диабетической ретинопатией // Оф-тальм. ведомости. - 2008. - Т. 1, № 1. - С. 58 - 64.
4. Amos A. et al. The rising global burden of diabetes and complication. Estimates and projections to the year 2010 // Diabet. med. - 1997. - Vol. 14. - P. 57 - 58.
5. Grundy S.M., Benjamin L.J., Burk G.L. et al. Diabetes and cardiovascular disease // A statement for healthcare professionals from the American Heart Associations Circulation. - 1999. - Vol. 100. - P. 1134-1146.
6. Haffner S.M. Coronary heart disease in patients with diabetes // N. Engl. J. Med. - 2002. -Vol. 342. - P. 1040-1042.
7. Howard B.V. Pathogenesis of diabetic dislipidemia // Diabetes Rev. - 1995. - Vol. 3. - P. 423 - 432.
8. Laakso M. Epidemiology of diabetic dislipidemia // Diabetes Rev. - 1995. - Vol. 3. - P. 408 - 422
9. Porta M., Kohner E.M. Screening for diabetic retinopathy in Europe // Diabetic Med. -1991. -Vol. 8. - P. 197-198.
10. Schields M.B. Glaucoma in diabetic patients. Ocular problems in diabetes mellitus // Blackwell scientific Publ. - Boston, 1992. - P. 307 - 319.
11. Syvanne M., Taskinen M.-R. Lipids and lipoproteins as coronary risk factors in non-insulin-dependend diabetes mellitus // Lancet. - 1997. -Vol. 350 (suppl. 1). - P. 583 - 568.
12. Furner R et al. Risk factors for coronary artery disease in non-insulin-depended diabetes mellitus // UKPDS Br. Med. J. 1998. - Vol. 216. - P. 823 - 828.
13. Wienpenger N.I., Mamputu J.S., Renier G. Antiatherogenic properties of metformin: the experimental evidence // Diabetes metabolism. - 2003. -P. 6571 -6577.
14. WHO. Diabetes eye disease / Prevention of diabetes mellitus. Report of WHO Study group // WHO Technical Report Series. - 1994. - N 844. - P. 49 - 55.
Review
For citations:
Balzhinimayev E.B., Zhigayev G.F., Ryabov M.P. DIABEFIT AND METMORFIN IN CORRECTION OF LIPID METABOLISM IN PATIENTS WITH DIABETIC RETINOPATHY. Acta Biomedica Scientifica. 2012;(6):13-16. (In Russ.)
Views:
500
.png)
Email this article 
